GlycoMimetics, Inc. GLYC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour GlycoMimetics, Inc. (GLYC), dont 36 achats et 14 ventes. Le total des achats d'initiés s'élève à $6.73M et le total des ventes d'initiés à $1.54M.

Les initiés notables ayant une activité récente comprennent Invus Public Equities, L.p., Siren, L.l.c., Rock Edwin. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — GLYC

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2024-08-08	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	260,873	$0.19	$50.01K	6,317,565
2024-08-07	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	61,488	$0.18	$11.2K	6,578,438
2024-08-06	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	55,732	$0.18	$10.19K	6,639,926
2024-08-05	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	164,523	$0.19	$31K	6,695,658
2024-08-02	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	286,200	$0.20	$57.35K	6,860,181
2024-08-01	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	63,564	$0.22	$13.74K	7,146,381
2024-07-30	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	756,835	$0.22	$167.18K	7,209,945
2024-07-29	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	363,949	$0.24	$85.64K	7,966,780
2024-07-26	Invus Public Equities, L.p.	10 Percent Owner	Vente Informative	258,335	$0.24	$62.44K	8,330,729
2024-07-25	Siren, L.l.c.	10 Percent Owner	Cession	-	-	-	8,589,064
2024-06-21	Rock Edwin	Chief Medical Officer	Achat Informatif	115,000	$0.27	$30.72K	680,403
2024-06-20	Rock Edwin	Chief Medical Officer	Achat Informatif	190,000	$0.25	$48.11K	565,403
2024-06-18	Hahn Brian M.	SVP Finance, CFO	Achat Informatif	17,500	$0.25	$4.33K	70,643
2024-05-01	Junius Daniel M	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	Andrews Patricia S	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	Pearson Timothy R	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	Goldberg Mark Alan	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	Jackson Scott Thomas	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	Koenig Scott	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-05-01	King Rachel K.	Director	Attribution de RSU	40,000	$1.62	$64.8K	40,000
2024-03-29	Junius Daniel M	Director	Attribution de RSU	5,209	$3.00	$15.63K	98,459
2024-03-29	Goldberg Mark Alan	Director	Attribution de RSU	4,584	$3.00	$13.75K	24,828
2024-03-29	King Rachel K.	Director	Attribution de RSU	3,334	$3.00	$10K	515,194
2024-01-12	Hahn Brian M.	SVP Finance, CFO	Attribution de RSU	250,000	$3.11	$777.5K	250,000
2024-01-12	Semerjian Harout	Chief Executive Officer	Attribution de RSU	695,000	$3.11	$2.16M	695,000
2024-01-12	Rock Edwin	Chief Medical Officer	Attribution de RSU	250,000	$3.11	$777.5K	250,000
2024-01-12	Rath Chinmaya	SVP and Chief Business Officer	Attribution de RSU	250,000	$3.11	$777.5K	250,000
2024-01-12	Johnson Bruce S	SVP & Chief Commercial Officer	Attribution de RSU	250,000	$3.11	$777.5K	250,000
2023-12-29	Andrews Patricia S	Director	Attribution de RSU	5,191	$2.36	$12.25K	58,608
2023-12-29	Goldberg Mark Alan	Director	Attribution de RSU	5,827	$2.36	$13.75K	20,244
2023-12-29	King Rachel K.	Director	Attribution de RSU	4,238	$2.36	$10K	511,860
2023-09-30	Andrews Patricia S	Director	Attribution de RSU	8,167	$1.50	$12.25K	53,417
2023-09-30	Goldberg Mark Alan	Director	Attribution de RSU	9,167	$1.50	$13.75K	14,417
2023-09-30	King Rachel K.	Director	Attribution de RSU	6,667	$1.50	$10K	507,622
2023-09-22	Rock Edwin	Chief Medical Officer	Achat Informatif	30,403	$1.38	$41.96K	375,403
2023-09-21	Rock Edwin	Chief Medical Officer	Achat Informatif	35,000	$1.38	$48.3K	345,000
2023-06-01	Koenig Scott	Director	Exercice d'Options (Vente)	21,000	$0.60	$12.6K	-
2023-05-19	Junius Daniel M	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	Andrews Patricia S	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	Pearson Timothy R	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	Goldberg Mark Alan	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	Jackson Scott Thomas	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	Koenig Scott	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-19	King Rachel K.	Director	Attribution de RSU	35,000	$1.98	$69.3K	35,000
2023-05-17	Hahn Brian M.	SVP Finance, CFO	Vente Informative	3,700	$1.95	$7.22K	53,143
2023-05-10	Junius Daniel M	Director	Achat Informatif	30,000	$1.56	$46.8K	93,250
2023-05-08	Johnson Bruce S	SVP & Chief Commercial Officer	Achat Informatif	13,500	$1.57	$21.2K	138,980
2023-03-23	Rath Chinmaya	SVP and Chief Business Officer	Cession	150,000	$3.48	$522K	-
2023-03-23	Johnson Bruce S	SVP & Chief Commercial Officer	Cession	200,000	$2.55	$510K	-
2023-02-24	Invus Public Equities, L.p.	10 Percent Owner	Achat Informatif	100,000	$1.70	$170K	8,589,064

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration